The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing
| Image |  |
|---|---|
| Description | scientific article published on May 2017 |
| Author/s |
author: Joep Killestein |
| Publication date | May 9, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |